跳转至内容
Merck
所有图片(1)

Key Documents

L-41(HeLa derivative)

96121716

登录查看公司和协议定价


About This Item

分類程式碼代碼:
41106514

生物源

human cervix

增長模式

Adherent

染色體組型

Not specified

形態學

Epithelial-like

產品

Not specified

受體

Not specified

技術

cell culture | mammalian: suitable

相關疾病

cancer

運輸包裝

dry ice

儲存溫度

−196°C

細胞系來源

Human cervix carcinoma

細胞系描述

The cell line L41 was reported to have been established by cloning the line J96, which was originally derived from the bone marrow of a child patient with leukaemia. However, it has been found to be indistinguishable from Hela by STR PCR DNA profiling.Therefore, the cell line should be considered as being derived from HeLa. The cell line L41 was mycoplasma eradicated at ECACC. Ethnicity: Black.

培養基

RPMI 1640 or DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).

例行更新培養

Split sub-confluent cultures (70-80%) 1:2 to 1:3 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C.

其他說明

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门